Delivery Order SPE2DB22D2206-SPE2DB25FJC48
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Neupogen 480 mcg/0.8 mL syringes. The contract is a firm-fixed-price delivery order with a ceiling value of $4,019.12 and a performance period through June 23, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, that serves as a comprehensive global...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of NEUPOGEN 480 MCG/0.8 ML SYR 0.8ML, a specialty pharmaceutical product. The contract has a firm fixed price of $17,160.11 and a period of performance through November 14, 2024. Amerisourcebergen is a major pharmaceutical distribution and healthcare solutions provider, and this contract is part of the company's broader Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award, valued at $3,644.34, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the NEUPOGEN 300 MCG/ML VIALML product, with a firm fixed price and an ultimate completion date of June 11, 2025. AmerisourceBergen Drug Corp, a for-profit organization, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- The U.S. Defense Logistics Agency awarded a Firm Fixed Price delivery order contract valued at $2,303.34 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract provides for the delivery of NEUPOGEN 300 MCG/ML VIALML pharmaceutical products to support federal government medical requirements. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support...
- This is a Delivery Order under a larger Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $999,999,999, provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple...
- AmerisourceBergen Drug Corp was awarded a delivery order on July 22, 2025, by the Defense Logistics Agency's Medical Supply Chain to supply FULPHILA 6 mg/0.6 mL syringes with a contract value of $10,523.70. The delivery order is structured as a firm fixed price contract with no set-aside designation, indicating it was competitively awarded. Performance of this delivery order will be completed by July 23, 2025, at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $440,289.24 by the Defense Logistics Agency's Medical Supply Chain on July 21, 2025, with an ultimate completion date of July 22, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a child delivery order under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The work will be...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $85,972.33 by the Defense Logistics Agency's Medical Supply Chain on July 23, 2025, with an ultimate completion date of July 24, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award was...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $16,062.16 by the Defense Logistics Agency's Medical Supply Chain on July 23, 2025. This firm fixed price, non-competitive delivery order represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The place of performance is listed as Conshohocken, Pennsylvania, AmerisourceBergen's corporate...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a $163,503.62 delivery order from the Defense Logistics Agency's Medical Supply Chain on July 24, 2025. This firm fixed-price, competitively awarded contract (no set-aside used) is a child order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The delivery order represents a single transaction within AmerisourceBergen's...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJC48Delivery Order
AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on July 28, 2025, for the supply of Neupogen 300 mcg/mL vials with a ceiling value of $2,429.58. This is a firm fixed price, competitive delivery order with no set-aside designation and a completion date of July 29, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion prime vendor vehicle valued through December 2026 that provides comprehensive pharmaceutical and medical supply support for military healthcare systems globally. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor that supplies a broad range of medications, vaccines, and medical devices to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. Neupogen (filgrastim) is a therapeutic agent used to support immune function, and this order demonstrates the company's role in fulfilling specialized pharmaceutical procurement requirements for federal military and veteran healthcare programs. The DLA Troop Support Medical contract vehicle enables flexible delivery of pharmaceutical commodities across multiple therapeutic domains to support operational readiness and patient care objectives worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 7/28/25 |